Indeed, Akt-mTOR activation was largely inhibited by MXRA5 shRNA or knockout in primary pancreatic cancer cells, but was augmented following ectopic overexpression of MXRA5. This evidence concerns the gene MXRA5 and pancreatic neoplasm.